Siegel, Eve External Author

Publications

Sort by

Selected publications

  • A phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancersAmerican Journal of Clinical Oncology: Cancer Clinical Trials2005 Academic Article GET IT
    Times cited: 10